TSX closed
Loading markets…

Advertisement

Stocks

DRI Healthcare Trust DHT-UN Earnings Miss Estimates by 6.7%

By Wealth Awesome -

Follow live quotes and coverage.

Stocks & ETFs:DHT-UN.TO

Follow DHT-UN

Photos provided by Pexels

DRI Healthcare Trust's latest earnings report shows a significant miss against expectations, raising questions about its future growth.

On August 7, 2026, DRI Healthcare Trust (DHT-UN.TO) reported its second-quarter earnings, revealing an EPS of $0.56, which fell short of analyst estimates of $0.60. This 6.67% miss is notable, especially considering the company's recent history of outperforming expectations in two of the last four quarters.

Recent earnings trend

Advertisement

DRI Healthcare Trust

DHT-UN.TO

Full stock page →

DHT-UN.TO

DRI Healthcare Trust

Source:WealthAwesomeWealthAwesome
$1.76 (10.56%)
120 day period
$15.75$17.70$19.65Apr 1Jun 26Sep 22

Market cap

$997.01M

Div. yield

2.43%

Div. / share

$0.42

52W high

$19.75

52W low

$13.63

1W change

+11.77%

Beta

0.67

Analyst Price Targets

Based on analyst covering DHT-UN · as of Sep 23, 2026

📈

Wall Street analysts forecast DHT-UN stock price to rise 29.6% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$23.86

+29.6% Upside

Previously C$23.24 on Sep 21, 2026

Current Price

C$18.42

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on DHT-UN's historical volatility

HistoricalForecast68%95%
C$14.12C$16.86C$19.59C$22.33C$25.07C$27.80TodayMay 14Jul 20Sep 22Nov 4Dec 18Jan 30

30-Day Vol

25.8%

Annualized

90-Day Vol

28.8%

Annualized

Trend (90d)

+20.6%

Annualized drift

90d Mean

C$19.82

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$18.88C$17.27C$20.64
60 trading daysC$19.34C$17.05C$21.94
90 trading daysC$19.82C$16.99C$23.13

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Analyst coverage: 4 analyst(s) cover this name; upcoming EPS consensus is available.

Beat estimates in 2 of the last 4 comparable quarter(s).

Fiscal periodReport dateActual EPSEstimateSurprise
2026-09-302026-11-050.5500
2026-06-302026-08-070.56000.6000-6.7%
2026-03-312026-05-140.68000.5500+23.6%
2025-12-312026-03-030.78000.5200+50.0%
2025-09-302025-11-050.55000.5500+0.0%
2025-06-302025-08-130.51000.4800+6.3%
0.00000.39000.7800 24-0924-1225-0325-0625-0925-1226-0326-06 Estimate Actual (≥0) Actual (<0) Wealth Awesome

Advertisement

Investor takeaway: While DRI Healthcare Trust's earnings miss raises concerns, the company has shown strong growth in total income and cash receipts, suggesting potential for recovery. Investors should pay attention to the strategic initiatives discussed in the earnings call, particularly the anticipated royalties from newly approved treatments.

EPS Misses by 6.7%, Total Income Up 13%

The reported EPS of $0.56 was below the consensus estimate of $0.60, indicating a possible gap in operational efficiency or market conditions affecting profitability.

Bull case

The company reported record Q2 results, with total income rising 13% year-over-year to $50.1 million and adjusted EBITDA climbing 40%. The strategic monetization of its Ekterly investment has improved liquidity for future growth initiatives, and the expected royalties from Lumvoa could provide additional revenue streams.

Bear case

Despite strong revenue growth, the EPS miss suggests potential challenges in managing costs or achieving profitability. The company's negative trailing twelve-month EPS and profit margin raise concerns about its long-term financial health.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile →

✅ Reviewed by Certified Financial Professionals

This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

📊 Data AccuracyVerified sources
🇨🇦 Canadian FocusLocal expertise
🔍 Fact-CheckedEditorial review

⚠️ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: August 11, 2026
Last Updated: August 11, 2026

Core portfolio

Awesome Portfolio™

15.1% a year since 2017, against 9.9% for the S&P/TSX Composite. Ten stocks, easy to manage. We update it once a month.

Annualized

+15.1%

Awesome Portfolio™

+9.9%

S&P/TSX

+5.2 pp better a year

Total return

+260%

Awesome Portfolio™

+137%

S&P/TSX

+123 pp better than the TSX

2017-07-31 to 2026-09-17, dividends reinvested, before fees and tax.

Awesome Portfolio™S&P/TSX CompositeCumulative return · 2017-07-31–2026-09-17
-11.7%42.8%97.2%151.6%206.0%260.4%Jul 17Oct 19Feb 22Jun 24Sep 26

Sponsored links

Advertisement